BofA Forecasts 'Broadly In Line' H1 Results from Wolters Kluwer; Buy Rating Maintained

06:24 AM EDT, 07/22/2026 (MT Newswires) -- BofA Global Research expects Wolters Kluwer (WKL.AS) to deliver "broadly in line" half-year results on Aug. 5. "That said, Wolters Kluwer has materially underperformed broader markets in 2026, leaving it trading on deeply discounted 8x CY26E EV/EBITDA, the lowest multiple in our [Business-to-Business] Media coverage. Whilst we don't dismiss AI risks in Health, they look more than adequately priced in. Meanwhile, we expect improving momentum in the Tax division to largely reassure, Legal continuing to perform (BofA 1H26E: 6.5% vs. cons: 5.4%) and reiteration of the full-year guide. Maintain Buy given "deep value", EUR95 [price objective]," the research firm said Tuesday. Aside from focusing on the group's tax and legal division performance, analysts expect investors to eye anticipated slower growth for Wolters Kluwer's financial and corporate compliance unit and stable results for its health division. BofA also projects the company's margins will benefit from second-half product development investments, creating potential upside for full-year 2026. For 2026, the Dutch professional information services company targets an adjusted operating profit margin of 28%, adjusted free cash flow of between 1.30 billion euros and 1.35 billion euros, along with high-single-digit adjusted EPS growth. BofA said the group's EPS outlook "remains achievable."